Zenas BioPharma, Inc.

SEC 4 · Filed

0001104659-26-075252Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 15, 2026

Grant, award or other acquisition by Boylan James P

Security
Stock Option (Right to Buy)
Code
A
Shares
18,500
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-15",
  "direction": "A",
  "exercise_price": "18.71",
  "expiration": "2036-06-15",
  "footnotes": {
    "F1": "The option vests as to 100% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, subject to continued service.",
    "F2": "The reporting person holds the stock option, and the shares underlying the option, for the benefit of Enavate Sciences, L.P. Accordingly, the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, if any."
  },
  "owners": [
    {
      "cik": "0001953094",
      "name": "Boylan James P",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "18500",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "18500",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "18500"
}